Axogen, Inc. Common Stock (AXGN)
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Headquarters
- United States
- Employees
- 622
- Market Cap
- $2.2B
About Axogen, Inc. Common Stock
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
SentiSense also tracks daily options readings for Axogen, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Axogen, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.